HK Stock MarketDetailed Quotes
08622 HUAKANG BIOMED
- 0.104
- +0.002+1.96%
Market Closed Apr 29 16:08 CST
52.05MMarket Cap-8000P/E (TTM)
0.104High0.098Low576.00KVolume0.101Open0.102Pre Close58.82KTurnover0.12%Turnover RatioLossP/E (Static)500.47MShares0.22252wk High0.93P/B52.05MFloat Cap0.09152wk Low--Dividend TTM500.47MShs Float0.540Historical High--Dividend LFY5.88%Amplitude0.091Historical Low0.102Avg Price8000Lot Size--Div YieldTTM--Div Yield LFY
HUAKANG BIOMED Key Stats
All
YOY
| (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q6)Jun 30, 2019 | (FY)Dec 31, 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 22.96%-3.01M | ---- | 65.68%-3.9M | ---- | -1,828.27%-11.37M | ---- | -47.02%658K | ---- | 602.83%1.24M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -124.58%-402K | ---- | 3.24%-179K | ---- | -6.32%-185K | ---- | -107.14%-174K | ---- | 41.26%-84K |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | ---- | --40K | ---- | ---- | ---- | ---- |
| Impairment and provisions: | --0 | 11.88%358K | --0 | -90.28%320K | --0 | 1,085.33%3.29M | --0 | -125.19%-334K | --0 | 1,537.04%1.33M |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | --2.56M | ---- | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | -41.44%373K | ---- | -19.06%637K | ---- | 414.80%787K | ---- | -117.92%-250K | ---- | 1,007.14%1.4M |
| -Other impairments and provisions | ---- | 95.27%-15K | ---- | -509.62%-317K | ---- | 38.10%-52K | ---- | -21.74%-84K | ---- | -53.33%-69K |
| Revaluation surplus: | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Asset sale loss (gain): | --0 | --0 | --0 | --0 | --0 | --0 | --0 | 0.00%-10K | --0 | ---10K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%-10K | ---- | ---10K |
| Depreciation and amortization: | --0 | 6.48%3.14M | --0 | -7.67%2.95M | --0 | 15.64%3.19M | --0 | 63.34%2.76M | --0 | 18.92%1.69M |
| -Depreciation | ---- | 2.16%2.75M | ---- | -6.15%2.69M | ---- | 19.73%2.86M | ---- | 78.51%2.39M | ---- | 25.12%1.34M |
| -Amortization of intangible assets | ---- | 50.96%394K | ---- | -20.91%261K | ---- | -10.81%330K | ---- | 5.41%370K | ---- | 0.00%351K |
| Financial expense | ---- | -46.08%55K | ---- | 37.84%102K | ---- | 2.78%74K | ---- | --72K | ---- | ---- |
| Special items | ---- | -75.79%46K | ---- | -92.92%190K | ---- | 89,300.00%2.68M | ---- | --3K | ---- | ---- |
| Operating profit before the change of operating capital | --0 | 136.47%190K | --0 | 77.11%-521K | --0 | -176.45%-2.28M | --0 | -28.52%2.98M | --0 | 256.90%4.17M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 164.14%1.05M | ---- | -2,493.65%-1.63M | ---- | 84.96%-63K | ---- | -23.60%-419K | ---- | -173.22%-339K |
| Accounts receivable (increase)decrease | ---- | -133.89%-141K | ---- | 113.38%416K | ---- | -409.87%-3.11M | ---- | 883.33%1M | ---- | -12.82%102K |
| Accounts payable increase (decrease) | ---- | 630.07%1.57M | ---- | -155.95%-296K | ---- | 110.00%529K | ---- | -320.17%-5.29M | ---- | -141.67%-1.26M |
| Cash from business operations | --0 | 187.79%1.76M | --0 | 34.56%-2.01M | --0 | -89.79%-3.07M | --0 | -160.89%-1.62M | --0 | -44.28%2.65M |
| Other taxs | ---- | -31.49%-476K | ---- | 57.76%-362K | ---- | 51.69%-857K | ---- | -4.17%-1.77M | ---- | ---1.7M |
| Interest paid - operating | ---- | ---- | ---- | ---9K | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items of business | ---- | -3,328.57%-904K | ---- | -98.49%28K | ---- | 1,538.05%1.85M | ---- | 853.33%113K | ---- | -200.00%-15K |
| Net cash from operations | 119.40%39K | 154.08%1.29M | 87.44%-201K | 39.40%-2.38M | 68.13%-1.6M | -15.75%-3.92M | 35.35%-5.02M | -456.47%-3.39M | -698.84%-7.77M | -64.76%951K |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | 124.58%402K | ---- | -3.24%179K | ---- | 6.32%185K | ---- | 107.14%174K | ---- | -41.26%84K |
| Loan receivable (increase) decrease | ---- | ---3.8M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | ---- | ---- | ---- | --97K | ---- | ---- | ---- | 0.00%10K | ---- | --10K |
| Purchase of fixed assets | ---- | 66.74%-649K | ---- | -12.06%-1.95M | ---- | -197.61%-1.74M | ---- | 0.68%-585K | ---- | 85.82%-589K |
| Cash on investment | ---- | -442.63%-2.06M | ---- | 0.00%-380K | ---- | 76.59%-380K | ---- | 28.25%-1.62M | ---- | -71.49%-2.26M |
| Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --300K |
| Net cash from investment operations | -175.94%-516K | -197.27%-6.11M | -48.41%-187K | -6.15%-2.06M | 81.95%-126K | 4.35%-1.94M | 27.82%-698K | 17.62%-2.02M | 50.28%-967K | 43.90%-2.46M |
| Net cash before financing | -22.94%-477K | -8.80%-4.82M | 77.52%-388K | 24.35%-4.43M | 69.82%-1.73M | -8.24%-5.86M | 34.52%-5.72M | -259.50%-5.41M | -1,247.84%-8.73M | 10.41%-1.51M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | 1,194.06%1.31M | ---- | --101K | ---- | ---- | ---- | ---- | ---- | ---- |
| Refund | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 99.11%-110K |
| Issuing shares | ---- | --2.31M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 163.15%43.86M |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -188.93%-7.26M |
| Other items of the financing business | ---- | 12.20%-1.29M | ---- | -32.52%-1.47M | ---- | -86.36%-1.11M | ---- | ---594K | ---- | ---- |
| Net cash from financing operations | 14.83%-356K | 270.13%2.32M | 5.22%-418K | -23.40%-1.37M | 57.14%-441K | -86.36%-1.11M | ---1.03M | -101.63%-594K | --0 | 554.21%36.49M |
| Effect of rate | -53.99%-328K | -753.23%-405K | -1,026.09%-213K | -47.46%62K | 866.67%23K | 2,850.00%118K | ---3K | --4K | ---- | ---- |
| Net Cash | -3.35%-833K | 56.91%-2.5M | 62.81%-806K | 16.76%-5.8M | 67.89%-2.17M | -15.96%-6.97M | 22.74%-6.75M | -117.17%-6.01M | -1,052.24%-8.73M | 797.77%34.99M |
| Begining period cash | -8.02%33.3M | -13.68%36.21M | -13.68%36.21M | -14.04%41.94M | -14.04%41.94M | -10.96%48.79M | -10.96%48.79M | 176.60%54.8M | 176.60%54.8M | 24.49%19.81M |
| Cash at the end | -8.66%32.14M | -8.02%33.3M | -11.59%35.19M | -13.68%36.21M | -5.33%39.8M | -14.04%41.94M | -8.73%42.04M | -10.96%48.79M | 141.76%46.06M | 176.60%54.8M |
| Cash balance analysis | ||||||||||
| Cash and cash equivalent balance | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | China Audit Zhonghuan (Hong Kong) Certified Public Accountants Limited | -- | China Audit Zhonghuan (Hong Kong) Certified Public Accountants Limited | -- | China Audit Zhonghuan (Hong Kong) Certified Public Accountants Limited | -- | China Audit Zhonghuan (Hong Kong) Certified Public Accountants Limited | -- | Deloitte & Touche Tohmatsu Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
%Chg